Terms: = Prostate cancer AND IL2, IL-2, 3558, ENSG00000109471, P60568 AND Clinical Outcome
6 results:
1. IL-6 and IL-8 cytokines are associated with elevated prostate-specific antigen levels among patients with adenocarcinoma of the prostate at the Uganda cancer Institute.
Katongole P; Sande OJ; Nabweyambo S; Joloba M; Kajumbula H; Kalungi S; Reynolds SJ; Ssebambulidde K; Atuheirwe M; Orem J; Niyonzima N
Future Oncol; 2022 Feb; 18(6):661-667. PubMed ID: 34881637
[No Abstract] [Full Text] [Related]
2. Treatment of Metastatic or High-Risk Solid cancer Patients by Targeting the Immune System and/or Tumor Burden: Six Cases Reports.
Nicolini A; Ferrari P; Morganti R; Carpi A
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795079
[TBL] [Abstract] [Full Text] [Related]
3. Elevated C1orf63 expression is correlated with CDK10 and predicts better outcome for advanced breast cancers: a retrospective study.
Hong CQ; Zhang F; You YJ; Qiu WL; Giuliano AE; Cui XJ; Zhang GJ; Cui YK
BMC Cancer; 2015 Jul; 15():548. PubMed ID: 26209438
[TBL] [Abstract] [Full Text] [Related]
4. In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients.
Meraviglia S; Eberl M; Vermijlen D; Todaro M; Buccheri S; Cicero G; La Mendola C; Guggino G; D'Asaro M; Orlando V; Scarpa F; Roberts A; Caccamo N; Stassi G; Dieli F; Hayday AC
Clin Exp Immunol; 2010 Aug; 161(2):290-7. PubMed ID: 20491785
[TBL] [Abstract] [Full Text] [Related]
5. Chronic immune activation and inflammation in the pathogenesis of AIDS and cancer.
Dalgleish AG; O'Byrne KJ
Adv Cancer Res; 2002; 84():231-76. PubMed ID: 11883529
[TBL] [Abstract] [Full Text] [Related]
6. Immunologic approaches to the treatment of prostate cancer.
Harris DT; Matyas GR; Gomella LG; Talor E; Winship MD; Spitler LE; Mastrangelo MJ
Semin Oncol; 1999 Aug; 26(4):439-47. PubMed ID: 10482186
[TBL] [Abstract] [Full Text] [Related]
